Grifols, S.A. (GRFS) reported a mixed second quarter for 2026, with revenue slipping to $2.1 billion from a year earlier, even as profitability improved sharply. Gross profit, operating profit, and net income all rose significantly, highlighting stronger margins and a much better bottom-line performance.
Key highlights from the release included:
Cash generation also improved, with operating cash flow rising to $257.3 million. The company spent $60.2 million on property, plant and equipment, while cash and cash equivalents stood at $585.5 million. Total liabilities were $13.8 billion, slightly lower than a year ago.
Shares of Grifols were up 2.66% in morning trading following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Grifols, S.A. Hedge Fund Activity
We have seen 81 institutional investors add shares of Grifols, S.A. stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BRANDES INVESTMENT PARTNERS, LP added 5,379,491 shares (+17.4%) to their portfolio in Q1 2026, for an estimated $43,143,517
- MILLENNIUM MANAGEMENT LLC removed 2,116,623 shares (-29.7%) from their portfolio in Q1 2026, for an estimated $16,975,316
- BANK OF MONTREAL /CAN/ removed 1,888,472 shares (-43.0%) from their portfolio in Q1 2026, for an estimated $15,145,545
- PERMIAN INVESTMENT PARTNERS, LP added 1,164,417 shares (+6.4%) to their portfolio in Q1 2026, for an estimated $9,338,624
- TIDAL INVESTMENTS LLC added 1,123,470 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,010,229
- BLACK CREEK INVESTMENT MANAGEMENT INC. removed 870,675 shares (-9.4%) from their portfolio in Q1 2026, for an estimated $6,982,813
- HARRIS ASSOCIATES L P removed 867,433 shares (-32.3%) from their portfolio in Q1 2026, for an estimated $6,956,812
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Grifols, S.A. Government Contracts
We have seen $1,560,626 of award payments to $GRFS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROLASTIN-C LIQUID,HUMAN 1000MG/VIL.: $363,999
- GRIFOLS REAGENTS - PROCLEIX ULTRIO ELITE, WEST NILE VIRUS, & BABESIA: $248,777
- GRIFOLS AUTOMATED IMMUNOHEMATOLOGY ANALYZER REAGENTS, SUPPLIES, AND SERVICE: $183,367
- PHARM - PROLASTIN-C: $120,000
- PHARM - PROLASTIN-C: $111,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
